Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors

Upsala Journal of Medical Sciences

Volumn 117, Issue 2, 2012, Pages 217-224

  Jögi, Annika ^a,b   Vaapil, Marica ^a,b   Johansson, Martin ^a   Påhlman, Sven ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Dedifferentiation; Differentiation; EMT; Hypoxia; Neuroblastoma; Prostate cancer; Skin cancer; Tumor stem cells; Tumor initiating cells

Indexed keywords

BREAST TUMOR; CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; NEOPLASM; NEUROBLASTOMA; PATHOLOGY; REVIEW;

BREAST NEOPLASMS; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; NEOPLASMS; NEUROBLASTOMA;

EID: 84859926397     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2012.659294     Document Type: Review

References (33)

1. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233:706-20. (Pubitemid 40853448)
2. Boström A-K, Möller C, Nilsson E, Elfving P, Axelson H, Johansson ME. Sarcomatoid renal cell carcinoma may denote a biological example of epithelial to mesenchymal transition. Hum Pathol. 2011.
3. Cushing H, Wolbach SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneur-oma. Am J Pathol. 1927;3(3):203-216.
4. Fredlund E, Ringner M, Maris JM, Påhlman S. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci USA. 2008;105:14094-9.
5. Påhlman S, Odelstad L, Larsson E, Grotte G, Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl- phorbol-13-acetate. Int J Cancer. 1981;28:583-9. (Pubitemid 11030489)
6. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst. 1982;68:589-96. (Pubitemid 12078843)
7. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC, Påhlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol. 1995;146:833-47.
8. Gestblom C, Hoehner JC, Hedborg F, Sandstedt B, Påhlman S. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am J Pathol. 1997;150:107-17. (Pubitemid 27027102)
9. Höckel M, Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266-76. (Pubitemid 32219813)
10. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757-63. (Pubitemid 24293585)
11. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29: 625-34.
12. Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle. 2007;6:919-26.
13. Jögi A, Persson P, Grynfeld A, Påhlman S, Axelson H. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem. 2002;277:9118-26. (Pubitemid 34952988)
14. Jögi A, Vallon-Christersson J, Holmquist L, Axelson H, Borg A, Påhlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res. 2004;295:469-87. (Pubitemid 38490500)
15. Pietras A, Johnsson AS, Påhlman S. The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol. 2010;345:1-20.
16. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30:393-402. (Pubitemid 351681994)
17. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, et al. Recruitment of HIF-1 alpha and HIF-2 alpha to common target genes is differentially regulated in neuroblastoma: HIF-2 alpha promotes an aggressive phenotype. Cancer Cell. 2006;10:413-23. (Pubitemid 44693470)
18. Pietras A, Gisselsson D, Øra I, Noguera R, Beckman S, Navarro S, et al. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol. 2008;214:482-8. (Pubitemid 351340568)
19. Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, et al. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascu-larization. Clin Cancer Res. 2009;15:7130-6.
20. LiZ, Bao S, Wu Q, WangH, Eyler C, Sathornsumetee S, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009;15:501-13.
21. Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjölund J, Gisselsson D, et al. HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA. 2009;106:16805-10.
22. Brisken C, Duss S. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 2007;3:147-56. (Pubitemid 350129717)
23. Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, et al. Hypoxia promotes a dedifferentiated phe-notype in ductal breast carcinoma in situ. Cancer Res. 2003; 63:1441-4. (Pubitemid 36373625)
24. Vaapil et al., unpublished paper.
25. Jögi A, Helczynska K, Vaapil M, Johansson E, Beckman S, Larsson C, et al. Hypoxia impairs morphological and functional differentiation of immortalized human breast epithelial cells in 3D basement membrane matrix-culture. Abstract #235. AACR Annual Conference. AACR 100th Annual Meeting, Denver, Colorado, April 18-22. 2009.
26. Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S, et al. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res. 2008;68:9212-20.
27. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100: 3983-8. (Pubitemid 36418143)
28. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133: 704-15. (Pubitemid 351636299)
29. Haase VH. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int. 2009;76:492-9.
30. Hoehner JC, Gestblom C, Hedborg F, Sandstedt B, Olsen L, Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest. 1996;75:659-75. (Pubitemid 26392797)
31. Odelstad L, Pahlman S, Nilsson K, Larsson E, Lackgren G, Johansson KE, et al. Neuron-specific enolase in relation to differentiation in human neuroblastoma. Brain Res. 1981;224: 69-82. (Pubitemid 11008167)
32. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761-5. (Pubitemid 44949605)
33. Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell. 2008;13: 69-80. (Pubitemid 350309742)